DOI: 10.1055/s-00000069

Seminars in Liver Disease

Issue 04 · Volume 29 · November 2009 DOI: 10.1055/s-002-20478 Advances in Drug-Induced Liver Injury Robert J Fontana M.D.

FOREWORD

  • 335
    Fontana, Robert J:

    Making the World a Safer Place

  • 337
    Bell, Lauren N; Chalasani, Naga:

    Epidemiology of Idiosyncratic Drug-Induced Liver Injury

  • 348
    Hayashi, Paul H:

    Causality Assessment in Drug-Induced Liver Injury

  • 357
    Björnsson, Einar:

    The Natural History of Drug-Induced Liver Injury

  • 364
    Kleiner, David E:

    The Pathology of Drug-Induced Liver Injury

  • 373
    Navarro, Victor J:

    Herbal and Dietary Supplement Hepatotoxicity

  • 383
    Uetrecht, Jack:

    Immunoallergic Drug-Induced Liver Injury in Humans

  • 393
    Watkins, Paul B:

    Biomarkers for the Diagnosis and Management of Drug-Induced Liver Injury

  • 400
    Daly, Ann K; Day, Chris P:

    Genetic Association Studies in Drug-Induced Liver Injury

  • 412
    Russo, Mark W; Scobey, Martin; Bonkovsky, Herbert L:

    Drug-Induced Liver Injury Associated with Statins

    • DIAGNOSTIC PROBLEMS IN HEPATOLOGY

  • 423
    Raja, Kaiser; Thung, Swan N; Fiel, M. Isabel; Chang, Charissa:

    Drug-Induced Steatohepatitis Leading to Cirrhosis: Long-Term Toxicity of Amiodarone Use